Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (161-170 of 320) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 11, 2020
The gut-brain axis in irritable bowel syndrome and inflammatory bowel diseaseAngela Ancona, Claudia Petito, Irene Iavarone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Crohn'S & Colitis 360|November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance StudiesBruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European ConsensusMassimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Nutrients|December 17, 2024
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective StudyCristina Bezzio, Daniele Brinch, Davide Giuseppe Ribaldone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2018
Unmet needs of Italian physicians managing patients with inflammatory bowel diseaseCristina Bezzio, Nicola Imperatore, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases|March 2, 2013
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remissionAlessandro Armuzzi, Daniela Pugliese, Silvio Danese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2023
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi, et al.
Pageof 32

Showing results (161-170 of 320) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 11, 2020
The gut-brain axis in irritable bowel syndrome and inflammatory bowel diseaseAngela Ancona, Claudia Petito, Irene Iavarone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2025
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER StudyGiuseppe Privitera, Lucia Monastero, Elena Melita, et al.
Crohn'S & Colitis 360|November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance StudiesBruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European ConsensusMassimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Nutrients|December 17, 2024
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective StudyCristina Bezzio, Daniele Brinch, Davide Giuseppe Ribaldone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2018
Unmet needs of Italian physicians managing patients with inflammatory bowel diseaseCristina Bezzio, Nicola Imperatore, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases|March 2, 2013
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remissionAlessandro Armuzzi, Daniela Pugliese, Silvio Danese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2023
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Claudio Papi, Ambrogio Orlando, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2022
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodologyFabio Salvatore Macaluso, Ambrogio Orlando, Claudio Papi, et al.
Pageof 32